BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23121581)

  • 1. Subsidised use of methylnaltrexone in Australia for palliative care.
    Rowett DS; Clark K; Robinson MK; Currow DC
    Med J Aust; 2012 Nov; 197(9):492. PubMed ID: 23121581
    [No Abstract]   [Full Text] [Related]  

  • 2. Methylnaltrexone for opioid-induced constipation in advanced illness.
    Sanz Rubiales A; del Valle Rivero ML
    N Engl J Med; 2008 Sep; 359(10):1070-1; author reply 1071. PubMed ID: 18768955
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of constipation in patients receiving palliative care.
    Cayley WE
    Am Fam Physician; 2011 Dec; 84(11):1227-8. PubMed ID: 22150655
    [No Abstract]   [Full Text] [Related]  

  • 4. Methylnaltrexone for the Treatment of Constipation in Critically Ill Children.
    López J; Fernández SN; Santiago MJ; Urbano J; González R; Fernández-Llamazares C; López-Herce J
    J Clin Gastroenterol; 2016 Apr; 50(4):351-2. PubMed ID: 26950234
    [No Abstract]   [Full Text] [Related]  

  • 5. Opioid side effects--mechanism-based therapy.
    Berde C; Nurko S
    N Engl J Med; 2008 May; 358(22):2400-2. PubMed ID: 18509126
    [No Abstract]   [Full Text] [Related]  

  • 6. Treating opioid-induced constipation with methylnaltrexone bromide.
    Kyle G
    Nurs Times; 2009 Feb 3-9; 105(4):25. PubMed ID: 19263773
    [No Abstract]   [Full Text] [Related]  

  • 7. Uptake of methylnaltrexone in Australian patients with opioid-induced constipation: a review of the number of prescriptions presented in the first 12 months of subsidisation.
    Clark K; Rowett D; Robinson M; Currow DC
    BMJ Support Palliat Care; 2013 Mar; 3(1):98-102. PubMed ID: 24644334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylnaltrexone: a subcutaneous treatment for opioid-induced constipation in palliative care patients.
    Kyle G
    Int J Palliat Nurs; 2009 Nov; 15(11):533-40. PubMed ID: 20081727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylnaltrexone bromide: new drug for the treatment of opioid-induced bowel dysfunction.
    Baker DE
    Rev Gastroenterol Disord; 2009; 9(3):E84-93. PubMed ID: 19898269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An overview of constipation and newer therapies.
    Enck RE
    Am J Hosp Palliat Care; 2009; 26(3):157-8. PubMed ID: 19531698
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of methylnaltrexone in opioid-induced constipation.
    Hellwig TR; Pottebaum AA
    S D Med; 2013 Oct; 66(10):425, 427. PubMed ID: 24244983
    [No Abstract]   [Full Text] [Related]  

  • 12. Methylnaltrexone: treatment for opioid-induced constipation--not convinced yet.
    HaiNan Liu ; Xiulu Ruan
    Am J Hosp Palliat Care; 2011 Jun; 28(4):290; author reply 291. PubMed ID: 21454318
    [No Abstract]   [Full Text] [Related]  

  • 13. Methylnaltrexone: treatment for opioid-induced constipation.
    Licup N; Baumrucker SJ
    Am J Hosp Palliat Care; 2011 Feb; 28(1):59-61. PubMed ID: 20801917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Food and Drug Administration approves methylnaltrexone bromide for opioid-induced constipation.
    Lang L
    Gastroenterology; 2008 Jul; 135(1):6. PubMed ID: 18549816
    [No Abstract]   [Full Text] [Related]  

  • 15. Methylnaltrexone treatment of opioid-induced constipation in patients with advanced illness.
    Chamberlain BH; Cross K; Winston JL; Thomas J; Wang W; Su C; Israel RJ
    J Pain Symptom Manage; 2009 Nov; 38(5):683-90. PubMed ID: 19713070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylnaltrexone for opioid-induced constipation in advanced illness.
    Chappell D; Rehm M; Conzen P
    N Engl J Med; 2008 Sep; 359(10):1071; author reply 1071. PubMed ID: 18777614
    [No Abstract]   [Full Text] [Related]  

  • 17. Methylnaltrexone (Relistor) for opioid induced constipation.
    Med Lett Drugs Ther; 2008 Aug; 50(1292):63-4. PubMed ID: 18688204
    [No Abstract]   [Full Text] [Related]  

  • 18. Paediatric palliative care: intravenous methylnaltrexone relieves constipation.
    Yeomanson D; Chohan O; Mayer A
    BMJ Support Palliat Care; 2013 Mar; 3(1):103-5. PubMed ID: 24644335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug approvals: '08 in review. Methylnaltrexone (Relistor).
    Laustsen G; Carrillo F; Johnson J; Smith C
    Nurse Pract; 2009 Feb; 34(2):31. PubMed ID: 19155882
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological treatment of constipation in palliative care.
    Clemens KE; Faust M; Jaspers B; Mikus G
    Curr Opin Support Palliat Care; 2013 Jun; 7(2):183-91. PubMed ID: 23478431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.